# Copeptin for Risk Stratification in Acute Stroke Patients: the CoRisk Study

> **NCT00878813** · — · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 1102 (actual)

## Conditions studied

- Stroke
- Transient Ischemic Attack

## Interventions

- **PROCEDURE:** Sampling of 15ml blood
- **PROCEDURE:** Blood-Sampling

## Key facts

- **NCT ID:** NCT00878813
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2011-04
- **Final completion:** 2011-10
- **Target enrollment:** 1102 (ACTUAL)
- **Last updated:** 2011-11-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00878813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00878813, "Copeptin for Risk Stratification in Acute Stroke Patients: the CoRisk Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00878813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*